Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Short-term Investments (2020 - 2025)

Rapid Micro Biosystems' Short-term Investments history spans 6 years, with the latest figure at $22.3 million for Q3 2025.

  • For Q3 2025, Short-term Investments fell 42.5% year-over-year to $22.3 million; the TTM value through Sep 2025 reached $22.3 million, down 42.5%, while the annual FY2024 figure was $33.8 million, 50.09% down from the prior year.
  • Short-term Investments for Q3 2025 was $22.3 million at Rapid Micro Biosystems, up from $12.9 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $81.6 million in Q4 2022 and bottomed at $12.9 million in Q2 2025.
  • The 5-year median for Short-term Investments is $38.8 million (2024), against an average of $46.8 million.
  • The largest annual shift saw Short-term Investments soared 439.93% in 2022 before it tumbled 59.96% in 2025.
  • A 5-year view of Short-term Investments shows it stood at $15.1 million in 2021, then skyrocketed by 439.93% to $81.6 million in 2022, then dropped by 16.93% to $67.8 million in 2023, then crashed by 50.09% to $33.8 million in 2024, then crashed by 34.06% to $22.3 million in 2025.
  • Per Business Quant, the three most recent readings for RPID's Short-term Investments are $22.3 million (Q3 2025), $12.9 million (Q2 2025), and $33.8 million (Q4 2024).